Affiner les résultats

Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis

Joerger, M. ; Matter-Walstra, K. ; Früh, M. ; Kühnel, U. ; Szucs, T. ; Pestalozzi, B. ; Schwenkglenks, M.

In: Annals of Oncology, 2011, vol. 22, no. 3, p. 567-574